Nuclein, LLC — Form D/A
Nuclein, LLC of AUSTIN, TX, a company, filed a Form D amendment with the SEC on 2026-02-05. The offering totals $15.0M, of which $9.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-02-05
- Form: D/A
- Accession: 0001787352-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $9.4M
- Remaining: $5.6M
- Investors: 34
- Date of first sale: 2025-01-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-537128
Issuer
- Name: Nuclein, LLC
- CIK: 0001787352
- Entity type: Limited Liability Company
- Jurisdiction: TEXAS
- Incorporated: 2017
- Address: 8305 CROSS PARK DR, AUSTIN, TX, 78754
- Phone: 512-879-3301
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Alan Blake | Related Person | Austin, TX |
| Douglas Bryant | Related Person | Austin, TX |
| Sanjay Chandra | Related Person | Southlake, TX |
| Richard Crockett | Related Person | Austin, TX |
| William Cunningham | Related Person | Austin, TX |
| Walter Narajowski | Related Person | Austin, TX |
| H. David Shockley | Related Person | Austin, TX |
| Jeffrey Stukuls | Related Person | Austin, TX |
| Richard Crockett | Director | Austin, TX |
| Richard Crockett | Executive Officer | Austin, TX |
| William Cunningham | Director | Austin, TX |
| Sanjay Chandra | Director | Southlake, TX |
| H. David Shockley | Director | Austin, TX |
| Walter David Narajowski | Director | Austin, TX |
| Alan Blake | Director | Austin, TX |
| Alan Blake | Executive Officer | Austin, TX |
| Douglas Bryant | Director | Austin, TX |
| Jeffrey David Stukuls | Executive Officer | Austin, TX |
| John Butler | Director | Lowell, MA |
| Walter Narajowski | Director | Austin, TX |
| David Shockley | Director | Austin, TX |
| Jeffrey Stukuls | Executive Officer | Austin, TX |
Other filings by this issuer (13)
More